Devices from Minnesota companies that save patients and hospitals money while improving outcomes and recovery times.
latest articles
For companies choosing locations for factories and offices, how big a role do taxes play?
Regulators want more information from Kips Bay Medical before allowing the company to conduct a U.S. clinical trial for its medical device; the device is currently being sold in six countries and has been implanted in roughly 250 patients.
Local companies using state-of-the-art videoconferencing are saving time and money.
A Minnesota program assists employers in clearing the hurdles to telecommuting.
Honoring corporate board members
NULL
The Partners in Preservation program has chosen 25 historic sites in the Twin Cities that will compete for a total of $1 million in preservation grants; residents can now vote on which sites will receive the grants.
The Pioneer Press reported that the company is enjoying a huge growth spurt this year and that it plans to move its headquarters to Eden Prairie in April to accommodate the growth.
Richard S. Willis replaces former CEO Cary Deacon, who left in April when the board made several bold moves and determined that the company needed a new leader to help grow its revenue.
The Minnesota Department of Commerce said the alleged scheme involved real estate companies, real estate closers, appraisers, mortgage brokers, and numerous buyers and defrauded lenders in the sale of at least 45 properties.
The two organizations said the new contract extends the Target Center naming rights partnership through 2014 and will allow them to gain a better understanding of the potential for future renovations to the arena.
The Minnetonka-based insurer and three other U.S. insurers will reportedly supply data to a newly created nonprofit group that will distribute it to researchers for analysis.
Klapmeier, who founded the Duluth-based company in a Wisconsin dairy barn with his brother 25 years ago, replaces Brent Wouters, who is no longer with Cirrus.
The firm's new research Web site is scheduled to launch on September 28 and will allow academics and investment professionals to share their white papers and other research on the hedge fund industry.
Michael Mahoney will assume the role of Boston Scientific president next month, but he can't supervise competing businesses or become CEO until November 2012 because of a non-compete agreement with Johnson & Johnson.